| Study of HLX22 in Combanition With Trastuzumab and Chemotherapy Versus Placebo in Combination With Trastuzumab and Chemotherapy for Treatment of Locally Advanced or Metastatic Gastric Cancer (NCT04908813) | Shanghai Henlius Biotech | 2021-09-29 |
| A Study of NX-1607 in Adults With Advanced Malignancies (NCT05107674) | Nurix Therapeutics, Inc. | 2021-09-29 |
| A Study to Assess the Safety and Efficacy of AZD7789 in Participants With Advanced or Metastatic Solid Cancer (NCT04931654) | AstraZeneca | 2021-09-28 |
| Comparative Study of Lobaplatin and Paclitaxel in Advanced Gastric Cancer Patients With D2 Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy (NCT04808466) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2021-09-18 |
| To Evaluate Efficacy of Ursodeoxycholic Acid (UDCA) for the Prevention of Gallstone Formation After Gasterectomy (NCT05410535) | Daewoong Pharmaceutical Co. LTD. | 2021-09-15 |
| The EpiGASTRIC/EDGAR Project: New Strategies for the Early Detection and Prevention of Gastric Cancer (NCT05551416) | EDUARDO ALBENIZ | 2021-09-09 |
| Clinical Study to Prove Safety and Effectiveness When Applying RUS™ Surgical Navigation (NCT05039333) | Hutom Corp | 2021-09-01 |
| Capnographic Monitoring in Gastrointestinal Endoscopy for Elderly Patients (NCT05030870) | RenJi Hospital | 2021-09-01 |
| TAS-102 and Anlotinib in ≥3 Lines mGC (NCT05029102) | Zhejiang University | 2021-09-01 |
| Dragon III-Phase 3: Neoadjuvant Chemotherapy (FLOT Versus SOX) for Gastric Cancer (NCT04384601) | Ruijin Hospital | 2021-09-01 |
| A Beta-only IL-2 ImmunoTherapY Study (NCT05086692) | Medicenna Therapeutics, Inc. | 2021-08-27 |
| Apatinib Combined With Chemotherapy Versus Chemotherapy in Second-line Gastric Cancer Receiving Prior Anti-PD-1 Therapy (NCT05029453) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2021-08-26 |
| Safety and Efficacy of Sintilimab in Combination With Chemoradiothrapy Followed by D2 Surgical Resection in Patients With Advanced Gastric Cancer With Retroperitoneal Lymph Node Metastasis (NCT05002686) | Ruijin Hospital | 2021-08-07 |
| A Study to Explore the Efficacy and Safety of Atezolizumab Plus Tiragolumab and Chemotherapy in 1st Line HER2 Negative Unresectable, Recurrent or Metastatic Gastric Cancer or Adenocarcinoma of Gastroesophageal Junction (GEJ) (NCT04933227) | Hoffmann-La Roche | 2021-08-06 |
| Study of DP303c Injection in Patients With Advanced or Metastatic Gastric Cancer (NCT04826107) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2021-08-01 |
| Prophylactic Preoperative HIPEC in Advanced Gastric Cancer at High Risk of Peritoneal Recurrence (NCT04597294) | Jagiellonian University | 2021-08-01 |
| Safety and Efficacy of Telatinib in Combination With Keytruda in Subjects With Advanced Stomach and Gastroesophageal Junction Cancers or Hepatocellular Carcinoma (NCT04798781) | Andrew Hendifar, MD | 2021-07-28 |
| Validating the Safety and Effectiveness of ENDOANGEL Upper Gastrointestinal Endoscope Image Auxiliary Diagnostic Software (NCT05470452) | The Second Affiliated Hospital of Chongqing Medical University | 2021-07-28 |
| Savolitinib for Treating Gastric Cancer and Esophagogastric Junction Adenocarcinoma Patients (NCT04923932) | Hutchison Medipharma Limited | 2021-07-27 |
| Perioperative Chemotherapy in Gastric Cancer (NCT04937738) | Ukrainian Society of Clinical Oncology | 2021-07-21 |
| Study of Adjuvant Chemotherapy With or Without PD-1 Inhibitors and Chemoradiotherapy in Resected pN3 Gastric (G) or GEJ Adenocarcinoma (NCT04997837) | Fudan University | 2021-07-21 |
| Anorexia iN Cancer Patients: ANCHOR (NCT04791254) | The Christie NHS Foundation Trust | 2021-07-15 |
| Survival Rates and Quality of Life According to Follow-up Period After Gastrectomy for Gastric Cancer (STOFOLUP) (NCT04740346) | National Cancer Center, Korea | 2021-07-05 |
| The Safety and Efficacy of PD-1 Monoantrapical Chemotherapy in the Treatment of Local Advanced Stomach Cancer (NCT05000554) | The First Hospital of Jilin University | 2021-07-02 |
| Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors (NCT04900818) | I-Mab Biopharma US Limited | 2021-06-29 |
| Study to Assess the Safety, Tolerability, and Efficacy of IDX-1197 in Combination With XELOX or Irinotecan in Patients With Advanced Gastric Cancer (NCT04725994) | Idience Co., Ltd. | 2021-06-28 |
| Peri-operative Sintilimab in Combination With SOX in Locally Advanced Gastric Cancer (NCT04982939) | Tianjin Medical University Cancer Institute and Hospital | 2021-06-21 |
| Pembrolizumab Plus Ramucirumab in Metastatic Gastric Cancer (NCT04632459) | Samsung Medical Center | 2021-06-16 |
| Octreotide Treatment to Improve Nutritional Recovery After Surgery for Patients with Esophageal or Gastric Cancer (NCT04871204) | Fredrik Klevebro | 2021-06-16 |
| Multi-Omics Noninvasive Inspection of TumOr Risk for Gastric Cancer (NCT04947995) | GeneCast Biotechnology Co., Ltd. | 2021-06-15 |
| Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE) (NCT04498767) | European Organisation for Research and Treatment of Cancer - EORTC | 2021-06-10 |
| Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies (NCT04913337) | NGM Biopharmaceuticals, Inc | 2021-06-09 |
| A Study of HC-5404-FU to Establish the Maximum Tolerated Dose (MTD) (NCT04834778) | HiberCell, Inc. | 2021-06-08 |
| Diagnostic Performance Indicators in Upper GI Endoscopy:PROSPERO Study (NCT04843397) | University of Cambridge | 2021-06-01 |
| CT and MRI in Prediction of Response in Patients With Gastric Cancer Following Neoadjuvant Chemotherapy and/or Immunotherapy (NCT04913896) | The First Hospital of Jilin University | 2021-06-01 |
| AB122 Platform Study (NCT04999761) | Taiho Pharmaceutical Co., Ltd. | 2021-06-01 |
| Development of Novel Gastric Cancer Screening and Diagnosis Technologies Using Tongue Imaging and Study of Tongue Image Changes Mechanisms (NCT06078930) | Zhejiang Cancer Hospital | 2021-06-01 |
| Real-world Data (RWD) of Ramucirumab Plus Paclitaxel (NCT04915807) | Hallym University Medical Center | 2021-06-01 |
| FLX475 Combined With Pembrolizumab in Patients With Advanced or Metastatic Gastric Cancer (NCT04768686) | Hanmi Pharmaceutical Company Limited | 2021-05-18 |
| Postoperative Prognosis Management Service Based mHealth for Gastric Cancer Patients (NCT04907591) | Samsung Medical Center | 2021-05-17 |
| Clinical Study of CD276 Targeted Autologous Chimeric Antigen Receptor T Cell Infusion in Patients With CD276 Positive Advanced Solid Tumor (NCT04864821) | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 2021-05-14 |
| Apatinib with Oxaliplatin and S-1 Treatment for Advanced Hepatoid Adenocarcinoma of the Stomach (NCT04863430) | Peking University | 2021-05-11 |
| TQB2450 Plus Anlotinib Combined With Chemotherapy in the Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma (NCT04891900) | Henan Cancer Hospital | 2021-05-10 |
| High-flow Nasal Cannula Oxygenation Decrease Hypoxia in Sedated Gastrointestinal Endoscopes in Obesity (NCT04500392) | RenJi Hospital | 2021-05-06 |
| Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors (NCT04902872) | Cybrexa Therapeutics | 2021-05-03 |
| PWP1's Expression in Gastric Cancer. (NCT06392750) | Northern Jiangsu People's Hospital | 2021-05-01 |
| CONFIRM: Magnetic Resonance Guided Radiation Therapy (NCT04368702) | Brigham and Women's Hospital | 2021-05-01 |
| ReStOre@Home: Feasibility Study of a 12-week Multidisciplinary Telehealth Rehabilitation Programme for Survivors of Upper Gastrointestinal (UGI) Cancer (NCT04603339) | University of Dublin, Trinity College | 2021-05-01 |
| Validation of an Artificial Intelligence System Based on Raman Spectroscopy for Diagnosis of Gastric Premalignant Lesions and Early Gastric Cancer (NCT04869618) | Changi General Hospital | 2021-05-01 |
| Comparison Between High-dose Amoxicillin Dual Therapy and Pylera Quadruple Therapy in the Treatment of Helicobacter Pylori Infection (NCT05100446) | Unidade Local de Saúde do Alto Ave, EPE | 2021-05-01 |
| Consistency Between Treatment Responses in PDO Models and Clinical Outcomes in Gastric Cancer (NCT05203549) | D1 Medical Technology (Shanghai) Co., Ltd, China | 2021-05-01 |
| Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody, in Advanced NSCLC and Other Solid Tumors, Alone and in Combination (NCT04868877) | Merus B.V. | 2021-04-28 |
| Relationship Between Standard Treatment Efficacy and The Tumor Microenvironment in Advanced Gastric Cancer (NCT04850716) | Nanfang Hospital, Southern Medical University | 2021-04-27 |
| FLOT Combined With PD-1 in the First-line Treatment of Patients With Advanced Gastric Cancer and Peritoneal Metastasis (NCT04886193) | Guangdong Provincial Hospital of Traditional Chinese Medicine | 2021-04-16 |
| In-hospital Outcomes of Older Patients With Gastric Cancer and Their Risk Factors (NCT06185907) | Ruijin Hospital | 2021-04-15 |
| Prediction of Gastric Cancer in Intestinal Metaplasia and Atrophic Gastritis (NCT04840056) | Chinese University of Hong Kong | 2021-04-15 |
| Study on the Peristaltic Direction of GI Anastomosis in Roux-en-Y Reconstruction (NCT04801459) | Tianjin Medical University Cancer Institute and Hospital | 2021-04-02 |
| Efficacy and Safety of Tirelizumab Plus Chemotherapy Versus Chemotherapy Alone in Patients With Lymph Node Positive Gastric Cancer After Surgery (NCT05844371) | Yixing People's Hospital | 2021-04-01 |
| TremelImumab aNd Durvalumab For the Non-operatIve Management (NOM) of MSI-high Resectable GC/GEJC. (NCT04817826) | Gruppo Oncologico del Nord-Ovest | 2021-04-01 |
| Fluorescence Image Guided Foregut Surgery (NCT04734821) | IHU Strasbourg | 2021-04-01 |
| The Effect of Perioperative Lidocaine Infusion on Neutrophil Extracellular Trapping (NCT04868747) | The Catholic University of Korea | 2021-04-01 |
| Helicobacter Pylori Local Prevalence and Antibiotic Resistance (NCT05561504) | Technical University of Munich | 2021-03-31 |
| A Phase 1 Study of SHR-A1811 in Patients With Selected HER2 Expressing Tumors (NCT04513223) | Jiangsu HengRui Medicine Co., Ltd. | 2021-03-30 |
| A Study of RC48-ADC in Local Advanced or Metastatic Gastric Cancer With the HER2-Overexpression (NCT04714190) | RemeGen Co., Ltd. | 2021-03-24 |
| A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies (NCT04772989) | Arcus Biosciences, Inc. | 2021-03-19 |
| Apatinib Monotherapy Versus Apatinib Combined With Camrelizumab for Third-line Treatment of Metastatic Gastric Cancer (NCT05095636) | Fudan University | 2021-03-17 |
| NuGa (Nutrition for Gastric Cancer Patients) (NCT04800991) | Seoul National University Hospital | 2021-03-17 |
| CTNNA1 Familial Expansion Study (NCT05126290) | Abramson Cancer Center at Penn Medicine | 2021-03-16 |
| Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors (NCT04742959) | TransThera Sciences (Nanjing), Inc. | 2021-03-14 |
| A Study of Atezolizumab and Trastuzumab in Combination With Capecitabine and Oxaliplatin in Patients With HER2 Positive Locally Advanced Resectable Gastric Cancer of Adenocarcinoma of Gastroesophageal Junction (NCT04661150) | Hoffmann-La Roche | 2021-03-12 |
| Neoadjuvant Immunotherapy and Chemotherapy for Locally Advanced Esophagogastric Junction and Gastric Cancer Trial (NCT04744649) | Nanfang Hospital, Southern Medical University | 2021-03-12 |
| The Effect of Intensive Dietary Education on Nutritional Status After Gastrectomy(SING) (NCT04798820) | Samsung Medical Center | 2021-03-09 |
| A Study of KF-0210 in Advanced Solid Tumors Patients (NCT04713891) | Keythera Pharmaceuticals (Australia) Pty Ltd | 2021-03-09 |
| Tislelizumab Combined With Anlotinib and Chemotherapy (XELOX) in the Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (TALENT) (NCT04963088) | The First Affiliated Hospital with Nanjing Medical University | 2021-03-06 |
| Docetaxel and Irinotecan in Gastric Cancer (NCT04770623) | Menoufia University | 2021-03-05 |
| Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors (NCT04579757) | Hutchmed | 2021-03-05 |
| Efficacy and Safety of Remimazolam Tosylate for Sedation in Gastroscopy (NCT04727034) | RenJi Hospital | 2021-03-02 |
| Tislelizumab Plus Anlotinib for Immunotherapy Resistant Gastrointestinal Cancer (NCT04777162) | Peking University | 2021-03-01 |
| Total Robotic Versus Robotic Assisted Distal Gastrectomy for Gastric Cancer (NCT04795063) | Fujian Medical University | 2021-03-01 |
| Preoperative Abdominal Enhanced CT, 18F-FDG PET/CT and 68Ga-FAPI PET/CT in Peritoneal Carcinomatosis of Gastric Cancer (NCT04778345) | Fujian Medical University | 2021-03-01 |
| A Web-based Calculator Predicts Heterogeneous Frailty Trajectories (NCT05982899) | Nanjing Medical University | 2021-03-01 |
| Preliminary Experimental Study on Key Technologies for Early Screening of Gastric Cancer (NCT05991947) | Zhejiang Cancer Hospital | 2021-03-01 |
| Carilizumab and Albumin Paclitaxel for Second-line Treatment of Advanced Gastric Cancer (NCT07320586) | Shandong Tumor Hospital | 2021-03-01 |
| BLI for the Diagnosis of Precancerous Conditions (NCT04768218) | Instituto Portugues de Oncologia, Francisco Gentil, Porto | 2021-03-01 |
| Handgrip Strength (HGS) With HGS Asymmetry Are Associated With All-cause Mortality and Hospital Readmissions (NCT05397444) | Nanjing Medical University | 2021-03-01 |
| Development and Validation of a Web-based Nomorgam to Predict Postoperative Complications (NCT05301699) | Nanjing Medical University | 2021-03-01 |
| Study of Sequential Systemic Therapy + Intraperitoneal Paclitaxel in Gastric/GEJ Peritoneal Carcinomatosis (NCT04762953) | University of California, Irvine | 2021-02-18 |
| DNX-2440 for Resectable Colorectal Liver Metastasis (NCT04714983) | DNAtrix, Inc. | 2021-02-15 |
| MAGNET (Magnetically Controlled Capsule for Assessment of Gastric Mucosa in Symptomatic Patients) (NCT04724291) | George Washington University | 2021-02-10 |
| Safety and Feasibility of Reversible Induction Strategy (NCT04434963) | RenJi Hospital | 2021-02-01 |
| Molecular and Epidemiological Risk Factors in the Development of Gastric Cancer (NCT04600466) | The University of Texas Health Science Center at San Antonio | 2021-01-22 |
| Infusional Fluorouracil and Weekly Docetaxel for Gastric Cancer With Bone Marrow Involvement and DIC (NCT04547153) | Sixth Affiliated Hospital, Sun Yat-sen University | 2021-01-15 |
| Oxaliplatin Combined With S-1(SOX) Neoadjuvant Chemotherapy for Different Cycles in Patients With Gastric Cancer (NCT04483076) | Chinese PLA General Hospital | 2021-01-13 |
| EndoVE endosCopic Treatment for Oesophageal and Gastric canceR (NCT04649372) | Mirai Medical | 2021-01-13 |
| Helicobacter Pylori Eradication With Berberine Plus Amoxicillin Triple Therapy Versus Bismuth-containing Quadruple Therapy (NCT04697186) | Xijing Hospital of Digestive Diseases | 2021-01-07 |
| SUrveillance of PREMalignant Stomach - Individualized Endoscopic Follow-up (NCT04613570) | Instituto Portugues de Oncologia, Francisco Gentil, Porto | 2021-01-02 |
| Proximal Gastrectomy Anterior Anastomosis With Pyloroplasty Versus Esophagogastric Anastomosis for Gastric Cancer (NCT05514769) | Nanchong Central Hospital | 2021-01-01 |
| Analysis of Influencing Factors of Preoperative Frailty in Elderly Patients With Gastric Cancer Based on the Health Ecology Theory (NCT04929587) | Nanjing Medical University | 2021-01-01 |
| Neoadjuvant Chemotherapy Plus Surgery Versus Surgery First For Elderly Gastric Cancer Patients (NCT04677673) | BIRENDRA KUMAR SAH | 2021-01-01 |
| Gastric Cancer Marker Detection and Its Kit Development (NCT05010863) | Second Affiliated Hospital of Wenzhou Medical University | 2021-01-01 |